Papers
57
Total Citations
1,030
H-Index
20
About
Riccardo Mastroianni is a prominent urological surgeon and researcher whose work sits at the intersection of robotic surgery, uro-oncology, and minimally invasive techniques. His research has profoundly shaped modern approaches to urological cancer treatment, with a particular focus on robot-assisted radical cystectomy, partial nephrectomy, and upper tract urothelial carcinoma management. Mastroianni's contributions span both the technical and patient-centered dimensions of robotic urology. His landmark historical review of robotic surgical systems, from PROBOT® to HUGO™, has already garnered 114 citations, establishing him as a leading voice in contextualizing the field's evolution. His involvement in randomized controlled trials comparing robot-assisted radical cystectomy with intracorporeal urinary diversion against open surgery — with 3-year outcomes now published — represents some of the highest-quality evidence in bladder cancer surgery. His work on off-clamp robotic partial nephrectomy for complex renal tumors, including predictive nomograms for post-operative kidney function decline, demonstrates his commitment to preserving renal tissue while maintaining oncological rigor. With contributions to multicenter international collaborations such as the ROBUUST group and a collective body of work exceeding 500 citations, Mastroianni has established himself as an influential figure driving evidence-based advances in robotic urological surgery worldwide.
Research Focus
Key Achievements
Top Papers
- 1Robotic Surgery in Urology: History from PROBOT® to HUGOTM114 citations · 2023
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10